Meloxoral

Active Ingredient:: Meloxicam
Brand:: Meloxoral
Origin:: European Union

Meloxoral (Meloxicam)

Meloxicam, the active ingredient in Meloxoral, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an unspecified dosage form for oral use. It reduces pain and inflammation associated with osteoarthritis, rheumatoid arthritis and other musculoskeletal conditions.

GNH India supplies Meloxoral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Meloxoral (meloxicam) is indicated for inflammatory and painful conditions affecting the musculoskeletal system.

Osteoarthritis: reduces joint pain and improves functional mobility.
Rheumatoid arthritis: alleviates synovial inflammation and joint swelling.
Acute pain: provides short‑term analgesic relief for post‑procedural or injury‑related pain.

How It Works

Meloxicam selectively inhibits the cyclooxygenase‑2 (COX‑2) enzyme, which decreases the conversion of arachidonic acid to prostaglandins. By lowering prostaglandin synthesis, it diminishes inflammation, pain signaling, and fever responses while sparing COX‑1 mediated gastric protection to a greater extent than non‑selective NSAIDs.

Side Effects

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

Gastrointestinal upset (nausea, dyspepsia)
Headache
Dizziness
Peripheral edema
Elevated blood pressure
Skin rash

Serious or Rare Side Effects

Gastrointestinal ulceration or bleeding
Cardiovascular events (myocardial infarction, stroke)
Hepatic enzyme elevation or hepatitis
Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis)
Renal impairment or failure
Anaphylaxis or severe hypersensitivity

Precautions & Warnings

Before initiating meloxicam therapy, clinicians should consider several safety measures.

Renal function assessment: monitor serum creatinine, especially in elderly or dehydrated patients.
Cardiovascular risk evaluation: use cautiously in patients with established heart disease or hypertension.
Gastro‑intestinal history review: avoid in individuals with active peptic ulcer disease or recent GI bleeding.
Concomitant NSAID avoidance: do not combine with other NSAIDs or aspirin without medical supervision.
Lowest effective dose: prescribe the minimal dose needed for symptom control and limit treatment duration.
Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Meloxoral can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
Lithium: elevated lithium serum concentrations leading to toxicity.
Methotrexate: enhanced methotrexate toxicity, especially renal impairment.
ACE inhibitors or diuretics: possible reduction in renal function.
Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely)

Other NSAIDs or aspirin: additive gastrointestinal toxicity.
Corticosteroids: increased risk of ulceration and bleeding.
Diuretics: potential for reduced antihypertensive effect.
Antihypertensive agents: may diminish blood pressure control.
Oral hypoglycemics: possible alteration of glucose control.

Frequently Asked Questions

Meloxoral contains meloxicam, an NSAID that is prescribed to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis and short‑term acute pain following injury or surgery.

Meloxicam works by selectively blocking the COX‑2 enzyme, which reduces the production of prostaglandins—chemicals that trigger inflammation, pain and fever—thereby providing anti‑inflammatory and analgesic effects.

The specific dose of Meloxoral is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, age, renal function and other individual factors. Patients should follow the prescriber’s instructions exactly.

Safety of meloxicam in pregnancy or while breastfeeding has not been fully established. Healthcare providers generally avoid NSAIDs in the third trimester and advise caution during lactation, weighing potential benefits against possible risks.

To request Meloxoral, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxoral (meloxicam) offers relatively selective COX‑2 inhibition compared with non‑selective NSAIDs such as ibuprofen or naproxen, which may translate into a lower incidence of gastrointestinal irritation while still providing effective pain relief.

Meloxoral should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability.

Meloxoral is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce occasional stomach discomfort.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions, liver enzyme elevation, and renal impairment. Patients should report any unusual symptoms promptly.

Meloxoral is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, and those who have had a recent coronary artery bypass graft. It should also be used with caution in patients with impaired kidney or liver function.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Meloxoral (Meloxicam)

Indications & Clinical Uses

How It Works